Product Information
LIRAGLUTIDE 5-PAK 18 MG/3 ML is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $47.6947 per ML under NDC 00480725046. Its NADAC has been published 36 times since Dec 17, 2025.
FDA first approved this application on Aug 27, 2025. Its Orange Book therapeutic-equivalence code is AP2.
Strength
6 mg/mL
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480725046
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
8/19/2026
Active Ingredients
LIRAGLUTIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214568FDA Approved
8/27/2025
TE Code
AP2
On Market Since
8/28/2025
Pharmacological Classes
Price Statistics
The NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has been published 36 times since Dec 17, 2025, and over the history we have for it it has declined 33.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $47.6947 per ML |
|---|---|
| All-time high | $73.7391 (Feb 11, 2026) |
| All-time low | $47.6947 (Aug 19, 2026) |
| 52-week high | $73.7391 |
| 52-week low | $47.6947 |
| Median price | $70.6417 |
| Average price | $67.9165 |
| Largest weekly change | -13.6% (Aug 19, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 33% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LIRAGLUTIDE 5-PAK 18 MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for LIRAGLUTIDE 5-PAK 18 MG/3 ML, manufactured by Teva Pharmaceuticals USA Inc., is $47.6947 per ML (NDC 00480725046), effective Aug 19, 2026.
How has the price of LIRAGLUTIDE 5-PAK 18 MG/3 ML changed over time?
Over the history we have for it, the NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has declined 33.5%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for LIRAGLUTIDE 5-PAK 18 MG/3 ML?
Since Dec 17, 2025, the NADAC for LIRAGLUTIDE 5-PAK 18 MG/3 ML has ranged from a low of $47.6947 (Aug 19, 2026) to a high of $73.7391 (Feb 11, 2026), with a median of $70.6417 per ML.
Are there cheaper alternatives to LIRAGLUTIDE 5-PAK 18 MG/3 ML?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LIRAGLUTIDE 3-PAK 18 MG/3 ML, is $32.0017 per ML — about 33% below LIRAGLUTIDE 5-PAK 18 MG/3 ML.
Who manufactures LIRAGLUTIDE 5-PAK 18 MG/3 ML?
LIRAGLUTIDE 5-PAK 18 MG/3 ML (NDC 00480725046) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.